Share-based Compensation Plans (Tables)

12 Months Ended

Jan. 31, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Weighted-Average Assumptions for Grants

The weighted-average assumptions for grants made during the periods presented, were as follows:


	Year Ended January 31,
	2022
Valuation assumptions:
Expected dividend yield	—	%
Expected volatility	68.26	%
Expected term (in years)	6.00
Risk-free interest rate	1.02	%

Schedule of Stock Options Roll Forward

Stock option activity during the period indicated is as follows, adjusted on a retroactive basis to reflect the Reverse Stock Split as discussed in Note 13, Stockholders’ Equity:


	Number of Shares	Weighted Average Exercise Price		Weighted Average Remaining Contract Term (in years)	Aggregate Intrinsic Value
Balances as of January 31, 2023	402,756	$	146.60	6.37	$	0.4
Granted	—	—
Exercised	—	—
Forfeited	(360,143)	145.20
Balances as of January 31, 2024	42,613	$	157.80	4.79	$	—
Exercisable as of January 31, 2024	39,383	$	155.40	4.70	$	—

Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity

RSUs activity during the period indicated is as follows, adjusted on a retroactive basis to reflect the Reverse Stock Split as discussed in Note 13, Stockholders’ Equity:


	Number of Shares	Weighted Average Grant-Date Fair Value per Share
Unvested and outstanding as of January 31, 2023	298,722	$	112.80
Granted	492,784	49.80
Vested/Released	(294,377)	87.00
Forfeited	(92,164)	82.80
Unvested and outstanding as of January 31, 2024	404,965	$	59.40

Share-based Payment Arrangement, Expensed and Capitalized, Amount

The classification of share-based compensation for the years ended January 31, 2024, 2023 and 2022, respectively, presented within each line item of the Consolidated Statements of Operations is as follows:


	Year Ended January 31,
	2024		2023		2022
Technology	$	5.5	$	5.9	$	4.2
Marketing	0.2		0.5		1.0
General and administrative	20.5		19.0		21.4
Total share-based compensation	$	26.2	$	25.4	$	26.6